Nectid Announces Initiation Of Clinical Development Of Autism And Pain Drugs
04:19 EDT 17 Aug 2012 | PR Newswire
This article has expired, however you can still
download the PDF.
Preview:
PRINCETON, N.J., Aug. 16, 2012 /PRNewswire/ -- Nectid, Inc. (www.nectid.com), a Princeton based pharmaceutical product development company focused on discovering and developing novel drugs, announced initiating clinical development of agomelatine for ...
Other Sources for this Article
More From BioPortfolio on "Nectid Announces Initiation Of Clinical Development Of Autism And Pain Drugs"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
